China outpacing Europe in drug innovation and development, Pfizer executive says

By Maggie Fick BRUSSELS, June 23 (Reuters) - China has pulled ahead of Europe in pharmaceutical innovation and drug ...

Pfizer CEO Albert Bourla reflects on leadership through Covid successes and post-pandemic challenges

A symbol of American pharmaceutical innovation for nearly two centuries, Pfizer now faces the challenges of AI adoption and the promise of smarter medicines. Pfizer CEO Albert Bourla discussed ...

Here's When Pfizer's CEO Says the Company Might Get Back to Generating High-Single-Digit Growth

Pfizer's business may be in better shape than investors think.
Wall Street Journal

Pfizer CEO Says Digging Out of Post-Covid Hole Will Take a Few More Years

Albert Bourla, Pfizer's chief executiveFabrice Coffrini/AFP/Getty Images Pfizer Chief Executive Albert Bourla is battling impending expirations for some blockbuster-drug patents and the precipitous ...
Hosted on MSN

Pfizer’s CEO on leading after a moonshot—and making deals with Trump

Good morning. What happens to an organization after it achieves a moonshot? That has been Albert Bourla’s reality, post-COVID. As the CEO of Pfizer, a company he first joined in 1993, Bourla—a ...